Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in XERS — Xeris Biopharma Holdings, Inc.

CIK 923093 STAMFORD, CT

Position in XERS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$623,001
+$448,841 QoQ
Shares Held
107,414
+384.2% QoQ
Ownership
0.062%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority Sole 50.ToString("F0")% Shared 50.ToString("F0")% None 0.ToString("F0")%

Common Shares in XERS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

TUDOR INVESTMENT CORP ET AL holds $23,421,840 across 9 Drug Manufacturers - Specialty & Generic names. XERS ranks #4 (2.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 XERS
Xeris Biopharma Holdings, Inc.
This page
107,414 $623,001

All Filings in XERS

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $623,001 107,414
2025-12-31 $174,160 22,186
2025-09-30 $309,271 37,994
2025-06-30 $1,051,618 225,186
2025-03-31 $1,236,271 225,186
2024-12-31 $1,034,580 305,186
2024-09-30 $1,445,967 507,357
2024-06-30 $1,289,668 573,186
2024-03-31 $1,266,741 573,186
2023-12-31 $1,300,515 553,411
2023-09-30 $1,193,186 641,498
2023-06-30 $2,249,036 858,411
2023-03-31 $1,564,980 960,111
2022-12-31 $1,276,947 960,111
2022-09-30 $1,497,773 960,111
2022-06-30 $1,478,570 960,111
2022-03-31 $2,460,651 961,192
2021-12-31 $2,813,125 960,111